Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-027256
Filing Date
2024-11-19
Accepted
2024-11-19 18:23:35
Documents
2
Period of Report
2024-11-11

Document Format Files

Seq Description Document Type Size
1 form3-11192024_111130.html 3  
1 form3-11192024_111130.xml 3 1754
2 ex24-11192024_111130.htm EX-24 7009
  Complete submission text file 0001415889-24-027256.txt   10142
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Issuer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATRECA, INC., 835 INDUSTRIAL RD. SUITE 400 SAN CARLOS CA 94070
Business Address
Ma Stacey (Reporting) CIK: 0001872431 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38661 | Film No.: 241477685